Artificial intelligence in colorectal liver metastases: From detection and resectability to treatment response and recurrence prediction
Artificial Intelligence in Cancer · 2026
DOI: 10.35713/aic.124432 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Intelligence in Cancer, 2026. Verfasst von Ahmed Salman und 2 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Colorectal cancer ranks among the commonest malignancies globally, and the liver is the main site of metastatic spread. Approximately 50% of patients develop colorectal liver metastases (CRLM), and its prognosis is strongly influenced by CRLM. The only practical route to cure is resection combined with systemic and locoregional therapy, but the decision-making is interlinked and guided only partially by qualitative imaging and standard clinicopathological tests. In this narrative review, we explore where artificial intelligence (AI) stands across the CRLM pathway: Lesion detection and characterization, deep-learning classification of histopathological growth patterns, automated volumetry and surgical planning, intraoperative guidance, prediction of response to systemic and ablative therapy, and estimation of recurrence and survival. AI performance is often equal to or better than expert performance for development cohorts and captures prognostic insight that is missed by qualitative reading. However, retrospective single-center design, small samples, inconsistent external validation, and fragile feature reproducibility hinder translation. Advances will rely on prospective multi-institutional testing, standardized reporting, privacy-preserving collaborative training, consideration of algorithmic bias and regulatory requirements, and integration of imaging, pathology, molecular, and clinical data. Nevertheless, AI has the potential to be an effective adjunct for interdisciplinary CRLM care.
Zitieren
APA
Salman, A., Elewa, A., & Salman, M. A. (2026). Artificial intelligence in colorectal liver metastases: From detection and resectability to treatment response and recurrence prediction. Artificial Intelligence in Cancer. https://doi.org/10.35713/aic.124432
Vancouver
Salman A, Elewa A, Salman MA. Artificial intelligence in colorectal liver metastases: From detection and resectability to treatment response and recurrence prediction. Artificial Intelligence in Cancer. 2026. doi:10.35713/aic.124432
BibTeX
@article{Salman2026,
author = {Salman, Ahmed and Elewa, Ahmed and Salman, Mohamed AbdAlla},
title = {Artificial intelligence in colorectal liver metastases: From detection and resectability to treatment response and recurrence prediction},
journal = {Artificial Intelligence in Cancer},
year = {2026},
doi = {10.35713/aic.124432}
}
EUVIMED